Replies to post #706 on Antiaging Quantum Living Inc (AAQL)

[north40000]

Chart not working well lately....$8.68 now in a general biotech sell-off.

[maverick_1]

When Wall St analysts are on the wrong side of the strategic issue as I pointed out in my first post:

maverick_1 Sunday, 03/08/15 02:46:40 PM
Re: None
Post # of 708
Strategic Assessment of why BMY'(or other Big Pharma) need to participate in a crowded, price competitive Hep C mkt is IMHO the key to it being a winner as ACHN is late to party and no collaboration.

HEP C Area WAS ripe.
ACHN has appreciated 5X from 52 wk lows
GILD and Abbie dominate and pricing pressures will continue
Does BMY (or other Big Pharma) want or need to further address HEP C and what are the catalysts that make strategic investment sense to BMY etc.

So altho ACHN's recent data is impressive but limited and I AM A NOVICE in ACHN that is why I have avoided ACHN in last two months despite institutional owners (not a significant holding of any instl IMHO). Looks controversial.

My preference: Better odds with investment success when either or both are at play:

EARLY in Industry Acceptance and/or Institutional acceptance

versus the current:

Industry sector has mushroomed and finds itself subject to pricing pressures induced by insurers and dealing with two entrenched key players.

ACHN may be a good trade for nimble ones, but better investment IF the above is laid out.

This post prompted by involvement of a few notable NWBO brethen.

on this board that was validated by MARKET RESPONSE to JNJ/ACHN deal recognizing that ALIO Rx a previous acquired co by JNJ Jansen for $1.7 Bln BUYOUT that underscores also what DewDiligence has also indicated: A WORKOUT vs a buyout.

SHS keep on making new short term lows and any "rally" is snuffed out.

Don't forget the LARGE capital raise pre-Spring 2015 @ $10.25 done at an already significant discount to market then: FEW 2nd's with that Wall St. following have been underwater like ACHN.

Sadly yet another of Pyrrhn rec's going SOUTH: only exception of a handful was CLDX.